Masahiro Maeda

2.1k citations
6 papers · 1.6k indexed · 1 hit paper · h-index 3
Topics
Chronic Lymphocytic Leukemia Research (2 papers)Signaling Pathways in Disease (1 paper)Myasthenia Gravis and Thymoma (1 paper)
Partner nations
JapanUnited StatesCanada

In The Last Decade

Masahiro Maeda

5 papers receiving 1.6k citations

Hit Papers

WT-1 is required for early kidney development1993202620042015199350010001.5k

Peers

Masahiro Maeda
Comparison fields: 5 of 67
  • Molecular Biology 1.4k
  • Genetics 490
  • Pulmonary and Respiratory Medicine 419
  • Pediatrics, Perinatology and Child Health 244
  • Public Health, Environmental and Occupational Health 240
Replace Joo-Seop Park with:
Joo-Seop Park United States
Florence Naillat Finland
Ryuji Fukuzawa Japan
Xuan Chi United States
David Grote Canada
Leslie A. McNoe New Zealand
Elizabeth Rapley United Kingdom
Mihaela Mureşan France
Nadja Bogdanova Germany
Michelle Self United States
Masahiro Maeda relative to Joo-Seop Park United States Joo-Seop Park's profile →
Citations per field
00.5×1.5×1.9×
Joo-Seop Park · 1×
Citations per year

Countries citing papers authored by Masahiro Maeda

Since Specialization
Citations

This map shows the geographic impact of Masahiro Maeda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masahiro Maeda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masahiro Maeda more than expected).

Fields of papers citing papers by Masahiro Maeda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masahiro Maeda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masahiro Maeda. The network helps show where Masahiro Maeda may publish in the future.

Co-authorship network of co-authors of Masahiro Maeda

This figure shows the co-authorship network connecting the top 25 collaborators of Masahiro Maeda. A scholar is included among the top collaborators of Masahiro Maeda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masahiro Maeda. Masahiro Maeda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
#WorkIndexed citations
1 0
2
[A Case of Acute Lymphoblastic Leukemia with Adult-Onset Still's Disease-Like Erythema].
1
3
[Chronic hepatitis C presenting with hepatic involvement by chronic lymphocytic leukemia responding to polyethylene glycol interferon-α-2b].
1
4 42
5
WT-1 is required for early kidney developmentbreakdown →
1531
6 19

About Masahiro Maeda

Masahiro Maeda is a scholar working on Genetics, Hematology and Public Health, Environmental and Occupational Health, having authored 6 papers that have together received 1.6k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (2 papers), Signaling Pathways in Disease (1 paper) and Myasthenia Gravis and Thymoma (1 paper). The work is most often cited by research in Urology (182 citations), Molecular Biology (1.4k citations) and Genetics (490 citations). Masahiro Maeda has collaborated with scholars based in Japan, United States and Canada. Frequent co-authors include Jerry Pelletier, Rudolf Jaenisch, Janet M. Loring, Hannu Sariola, Jordan A. Kreidberg, David E. Housman, Akira Yamanaka, Shigeki Saiki, Suzuko Moritani and Yoshiki Murakumo. Their work appears in journals such as Cell, Pathology International and PubMed.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026